Dimensional Fund Advisors LP
- SEC CIK
- 0000354204
- Latest filing
- Aug 11, 2026
KNTE holding history
Kinnate Biopharma Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KNTE overviewAll 13F holders of KNTEFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −91,961−100.0% | Sold out | Holders |
| Q1 2024 | 91,961 | $244.6K | <0.1% | +77,368+530.2% | Added | Holders |
| Q4 2023 | 14,593 | $34.7K | <0.1% | +2,344+19.1% | Added | Holders |
| Q3 2023 | 12,249 | $17.1K | <0.1% | −13,335−52.1% | Reduced | Holders |
| Q2 2023 | 25,584 | $77.8K | <0.1% | −6,962−21.4% | Reduced | Holders |
| Q1 2023 | 32,546 | $203.2K | <0.1% | −5,852−15.2% | Reduced | Holders |
| Q4 2022 | 38,398 | $234.0K | <0.1% | −510−1.3% | Reduced | Holders |
| Q3 2022 | 38,908 | $465.0K | <0.1% | +7,515+23.9% | Added | Holders |
| Q2 2022 | 31,393 | $396.0K | <0.1% | +31,393 | New | Holders |